• HOME
  • ISSUES
  • EXPLORE CONTENT
    • Introduction
    • Articles
    • Book Reviews
    • Case Reports
    • News
    • Sponsored Editorial
  • EVENTS
    • Introduction
    • Event News
    • Conference Reports
    • Submit your event to ACNR
  • AUTHORS
    • Introduction
    • ACNR Author Guidelines
    • Author Disclosure
  • RESOURCES
  • ABOUT
    • Introduction
    • How is ACNR funded?
    • Editorial Board
    • Peer Reviewers
    • Policies and Forms
    • Ethics and Malpractice
    • Email Newsletter
    • Mail Signup
    • ACNR Privacy Policy
This website is intended for healthcare professionals
ACNR
  • HOME
  • ISSUES
  • EXPLORE CONTENT
    • Introduction
    • From the Editor
    • Articles
      • View All
      • Peer Reviewed
      • Personal Perspectives
      • History
    • Book Reviews
    • Case Reports
    • News
    • Sponsored Editorial
  • EVENTS
    • Introduction
    • Event News
    • Conference Reports
    • Submit your Course or Conference
  • AUTHORS
    • Introduction
    • ACNR Author Guidelines
    • Author Disclosure
  • RESOURCES
  • ABOUT
    • Introduction
    • How is ACNR Funded?
    • Editorial Board
    • Peer Reviewers
    • ACNR Policies and Forms
    • Ethics and Malpractice
    • Email Newsletter
    • Journal Signup
    • ACNR Privacy Policy
  • Menu

New data from Biogen reinforce long-term benefits of Tecfidera® (Dimethyl Fumarate) over 10 years

Posted on 13 September, 2019 - Industry News

News from Biogen at #ECTRIMS19

Roche’s satralizumab significantly reduced relapse risk in second positive phase III study for neuromyelitis optica spectrum

Posted on 13 September, 2019 - Industry News

News from Roche at #ECTRIMS19

New Real-World Data Support Long-Term Efficacy and Safety Profile of MAVENCLAD®

Posted on 13 September, 2019 - Industry News

News of Mavenclad from #ECTRIMS19

Imcyse to present positive results in EAE model of multiple sclerosis at ECTRIMS 2019

Posted on 12 September, 2019 - Industry News

News from #ECTRIMS19

Improved NHS care for Parkinson’s, Multiple Sclerosis and Motor Neurone Disease to save 2,500 hospital trips

Posted on 10 September, 2019 - Industry News

New online toolkit from the NHS

PathMaker Neurosystems – Publication of First Clinical Trial Results for MyoRegulator® Device for Non-Invasive Treatment of Spasticity

Posted on 19 August, 2019 - Industry News

News from PathMaker Neurosystems Inc.

Improving management of headache, migraine and chronic pain

Posted on 1 August, 2019 - Industry News, Neurology News

News of the Elective Care Transformation Programme

IQoro for stroke-related dysphagia

Posted on 1 August, 2019 - Industry News

News of IQoro

Neurological Alliance Report shows increasing number of neurological cases

Posted on 1 August, 2019 - Industry News, Neurology News

News from the Neurological Alliance

  • «
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 49
  • »

Recent News

  •  A blood test for early cognitive decline?
  • Tavapadon: A game-changing partial dopamine agonist?
  • New mechanism for blood flow regulation in the brain
  • Sleep apnoea linked to changes in the brain
  • Genetic testing for neurodevelopmental conditions
  • ‘Digital twin’ brain tech for people with Parkinson’s given funding
  • Accelerated Approval in Huntington’s disease?
  • Vamorolone for Duchenne Muscular Dystrophy
  • Episodic migraine in children and adolescents
  • A link between gut bacteria and Alzheimer’s disease?

Categories

  • ACNR News (8)
  • Acquired Brain Injury (14)
  • Alzheimer's Disease (27)
  • Amyotrophic Lateral Sclerosis (ALS) (7)
  • Artificial Intelligence (6)
  • Association of British Neurologists Trainees (4)
  • Australia/New Zealand (1)
  • Awards & Appointments (10)
  • Book Reviews (2)
  • Brain Mapping (2)
  • Brain tumours (3)
  • Case Reports (15)
  • Charcot-Marie-Tooth Disease (1)
  • Charity (5)
  • Cognition (3)
  • Comment (2)
  • Course & Conference Previews (11)
  • Courses & Conferences (1)
  • COVID-19 Articles (4)
  • Dementia (12)
  • Digital Health (2)
  • Epilepsy (16)
  • Essay (1)
  • Genetics (1)
  • Headache (17)
  • Hereditary Spastic Paraplegia (1)
  • Huntington's disease (4)
  • Industry News (178)
  • Journal Reviews (1)
  • Major Depressive Disorder (3)
  • Management Topics in Epilepsy (1)
  • Movement Disorders (14)
  • Multiple Sclerosis (27)
  • Myasthenia Gravis (7)
  • Neurodegenerative diseases (1)
  • Neurodevelopmental disorders (4)
  • Neuroimmunology (2)
  • Neurological Literature (2)
  • Neurology News (37)
  • Neuromuscular (1)
  • Neuropsychiatry (2)
  • Neurosurgery (1)
  • NHS News (2)
  • Online First (14)
  • Pain (4)
  • Parkinson’s Disease (28)
  • Rehabilitation (10)
  • Rehabilitation Articles (4)
  • Research (6)
  • Sleep (3)
  • Sleep Series (4)
  • Special Feature (6)
  • Sponsored Feature (7)
  • Stroke (10)
  • Stroke Series (3)
  • Syncope (1)
  • Uncategorised (45)
  • Uncategorized (1)
  • Published by Whitehouse Publishing
  • The Lynch, Mere, Wiltshire BA12 6DQ, United Kingdom
  • info@acnr.co.uk
  • +44 1747 860168

FOLLOW US

  • Facebook
  • Instagram
  • X
  • Linkedin

RSS FEEDS

  • ACNR RSS
  • All
  • Articles
  • Events

ACNR SIGNUPS

Join our email list to be notified when there is new content or upcoming events. For UK-based specialists join our journal mailing list.

© 2024 ACNR. Published by Whitehouse Publishing. Read our Privacy and Cookie Policy. Website by Sugar Web.

SIGN UP FOR OUR EMAILING LIST

Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified.

For UK-based specialists, sign up for our journal mailing list.

WARNING

URL here

You are now leaving the ACNR website, please click the "Continue" button below. If you do not wish to leave, please close this pop-up.

Continue